| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10974-009-9197-6 |
| P698 | PubMed publication ID | 20082121 |
| P2093 | author name string | Kay Ohlendieck | |
| Caroline Lewis | |||
| Steven Carberry | |||
| P2860 | cites work | Current two-dimensional electrophoresis technology for proteomics | Q22252855 |
| Glucocorticoid corticosteroids for Duchenne muscular dystrophy | Q24242199 | ||
| Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle | Q24308714 | ||
| Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle | Q24538577 | ||
| Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study | Q24643018 | ||
| Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling | Q24815340 | ||
| Inhibitory control over Ca(2+) sparks via mechanosensitive channels is disrupted in dystrophin deficient muscle but restored by mini-dystrophin expression | Q27438151 | ||
| The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein | Q28118471 | ||
| The human plasma proteome: history, character, and diagnostic prospects | Q28218148 | ||
| Electrospray ionization for mass spectrometry of large biomolecules | Q29618001 | ||
| Matrix-Assisted Laser Desorption Ionization Mass Spectrometry: Applications in Peptide and Protein Characterization | Q30417385 | ||
| The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins | Q30966472 | ||
| Proteomic analysis of mdx skeletal muscle: Great reduction of adenylate kinase 1 expression and enzymatic activity | Q31027117 | ||
| Differential expression of the skeletal muscle proteome in mdx mice at different ages. | Q33205614 | ||
| Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. | Q33234154 | ||
| Mass spectrometry and protein analysis | Q33239890 | ||
| Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. | Q33249876 | ||
| Mass spectrometry technologies for proteomics | Q33268106 | ||
| Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy | Q33328023 | ||
| Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm. | Q33398588 | ||
| Dystroglycan inside and out. | Q33744965 | ||
| Animal models for muscular dystrophy: valuable tools for the development of therapies | Q34045919 | ||
| Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene | Q34190227 | ||
| Evolution of the alpha-crystallin/small heat-shock protein family | Q34361727 | ||
| Limb-girdle muscular dystrophies | Q34573570 | ||
| Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy | Q34586999 | ||
| Proteomic analysis of striated muscle | Q34642389 | ||
| Is proteomics the new genomics? | Q34662107 | ||
| Muscular dystrophy into the new millennium | Q34682745 | ||
| Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. | Q34699458 | ||
| Elevated subsarcolemmal Ca2+ in mdx mouse skeletal muscle fibers detected with Ca2+-activated K+ channels. | Q35700706 | ||
| The development of the DIGE system: 2D fluorescence difference gel analysis technology | Q36131099 | ||
| Molecular and cell biology of the sarcoglycan complex | Q36152977 | ||
| Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology | Q36360412 | ||
| Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry | Q36577758 | ||
| Dystrobrevins in muscle and non-muscle tissues. | Q36717600 | ||
| Dystrophic skeletal muscle fibers display alterations at the level of calcium microdomains | Q36936452 | ||
| Emerging strategies for cell and gene therapy of the muscular dystrophies | Q36960845 | ||
| Biology of the striated muscle dystrophin-glycoprotein complex | Q37085050 | ||
| The therapeutic potential of antisense-mediated exon skipping | Q37127482 | ||
| Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome | Q37149236 | ||
| Complementary methods to assist subcellular fractionation in organellar proteomics | Q37257664 | ||
| Exon skipping and Duchenne muscular dystrophy: hope, hype and how feasible? | Q37313819 | ||
| Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling | Q37338902 | ||
| Power and limitations of electrophoretic separations in proteomics strategies. | Q37346251 | ||
| Proteomics of skeletal muscle aging | Q37380758 | ||
| Exon-skipping therapy for Duchenne muscular dystrophy | Q37503677 | ||
| Diagnosis and new treatments in muscular dystrophies | Q37521427 | ||
| Proteomic profiling of animal models mimicking skeletal muscle disorders | Q37817162 | ||
| Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility | Q39260422 | ||
| Two-dimensional difference gel electrophoresis | Q39792303 | ||
| Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. | Q40612428 | ||
| The structural and functional diversity of dystrophin | Q40644356 | ||
| Chaperone activity of alpha-crystallins modulates intermediate filament assembly. | Q40790972 | ||
| Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. | Q40958054 | ||
| Dystrophies and heart disease. | Q41550717 | ||
| Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes | Q41726707 | ||
| Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy. | Q41823396 | ||
| Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers | Q41882302 | ||
| Structural and functional analysis of the sarcoglycan-sarcospan subcomplex | Q42712728 | ||
| Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma | Q43107646 | ||
| Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle | Q43858043 | ||
| Sarcoplasmic reticulum function in slow- and fast-twitch skeletal muscles from mdx mice | Q44113196 | ||
| The action potential-evoked sarcoplasmic reticulum calcium release is impaired in mdx mouse muscle fibres | Q44788698 | ||
| Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice | Q44913842 | ||
| Subproteomics analysis of Ca+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle | Q45063439 | ||
| Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle. | Q45982332 | ||
| A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart | Q46043712 | ||
| Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: a potential role in calcium buffering and sarcolemmal stability. | Q46161936 | ||
| Regulation of cell proliferation by fast Myosin light chain 1 in myoblasts derived from extraocular muscle, diaphragm and gastrocnemius | Q46288810 | ||
| Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage | Q46528995 | ||
| TRPC1 binds to caveolin-3 and is regulated by Src kinase - role in Duchenne muscular dystrophy | Q46547351 | ||
| Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology | Q46917397 | ||
| Comparative proteomic profile of rat sciatic nerve and gastrocnemius muscle tissues in ageing by 2-D DIGE. | Q51743242 | ||
| Sarcoplasmic-endoplasmic-reticulum Ca2+-ATPase and calsequestrin are overexpressed in spared intrinsic laryngeal muscles of dystrophin-deficient mdx mice. | Q51757790 | ||
| Expression of heat-shock/stress proteins in Duchenne muscular dystrophy. | Q52211391 | ||
| Distal mdx muscle groups exhibiting up-regulation of utrophin and rescue of dystrophin-associated glycoproteins exemplify a protected phenotype in muscular dystrophy. | Q53969078 | ||
| PROTEOMICS (article) | Q57374628 | ||
| The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy | Q59051261 | ||
| Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle | Q59089242 | ||
| Ultrastructural localization of dystrophin in human muscle by using gold immunolabelling | Q68091120 | ||
| Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle | Q68255626 | ||
| The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates | Q68984568 | ||
| The molecular basis of muscular dystrophy in the mdx mouse: a point mutation | Q69514522 | ||
| Dystrophin constitutes 5% of membrane cytoskeleton in skeletal muscle | Q70177916 | ||
| Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma | Q70651010 | ||
| Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan | Q73512517 | ||
| The muscular dystrophies | Q77731754 | ||
| Transient receptor potential cation channels in normal and dystrophic mdx muscle | Q81338799 | ||
| Laryngeal muscles are spared in the dystrophin deficient mdx mouse | Q81343725 | ||
| Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles | Q82770599 | ||
| Difference gel electrophoresis | Q84046993 | ||
| P433 | issue | 7-8 | |
| P304 | page(s) | 267-269 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Journal of Muscle Research & Cell Motility | Q13739445 |
| P1476 | title | Proteomic profiling of x-linked muscular dystrophy | |
| P478 | volume | 30 |
| Q34463331 | A combined laser microdissection and mass spectrometry approach reveals new disease relevant proteins accumulating in aggregates of filaminopathy patients |
| Q39123718 | A new look at cytoskeletal NOS-1 and β-dystroglycan changes in developing muscle and brain in control and mdx dystrophic mice |
| Q33565229 | Application of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy research |
| Q38217473 | Chaperoning heat shock proteins: proteomic analysis and relevance for normal and dystrophin-deficient muscle. |
| Q37196136 | Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy |
| Q34703663 | Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy |
| Q33707960 | Exon-skipped dystrophins for treatment of Duchenne muscular dystrophy: mass spectrometry mapping of most exons and cooperative domain designs based on single molecule mechanics |
| Q36856938 | HSPB7 interacts with dimerized FLNC and its absence results in progressive myopathy in skeletal muscles. |
| Q35212100 | MALDI imaging mass spectrometry: discrimination of pathophysiological regions in traumatized skeletal muscle by characteristic peptide signatures |
| Q36316393 | Profiling of age-related changes in the tibialis anterior muscle proteome of the mdx mouse model of dystrophinopathy |
| Q38079622 | Proteomic identification of biomarkers of skeletal muscle disorders. |
| Q44232941 | Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin |
| Q36883472 | Proteomic profiling of skeletal muscle plasticity |
| Q38115329 | Proteomic profiling of the contractile apparatus from skeletal muscle. |
| Q36613670 | Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophy |
| Q38391853 | Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells. |
| Q35201194 | Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle |
| Q40728538 | Reduction in mdx mouse muscle degeneration by low-intensity endurance exercise: a proteomic analysis in quadriceps muscle of exercised compared with sedentary mdx mice |
| Q35128702 | Skeletal muscle proteomics: current approaches, technical challenges and emerging techniques |
Search more.